Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • A randomized trial of once daily versus twice daily dosing of oral iron in CKD

    Scientific Reports Date published:

  • Patterns of multimorbidity among a community-based cohort in rural India

    Journal of Multimorbidity and Comorbidity Date published:

  • Trends in the Global Burden of Glomerulonephritis

    Clinical Journal of the American Society of Nephrology Date published:

  • Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu

    Kidney International Date published:

  • Infectious Complications and Vaccination in Chronic Kidney Disease

    Management of Chronic Kidney Disease Date published:

  • Diabetes and CKD

    Management of Kidney Diseases Date published:

  • Investigating Kidney Disease

    Management of Kidney Diseases Date published:

  • The Approach to the Patient with Kidney Disease

    Management of Kidney Diseases Date published:

  • Management of Kidney Diseases

    Management of Kidney Diseases Date published:

  • Acute Kidney Injury in the Tropics

    pan class="rg-author">Burdmann EA; Jha V; Srisawat N, 2023, 'Acute Kidney Injury in the Tropics', in Comprehensive Clinical Nephrology Date published:

  • Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study

    Frontiers in Medicine Date published:

  • ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

    Trials Date published:

  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial

    Unknown Date published:

  • Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

    BMJ Date published:

  • Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID -19 and severe hypoxaemia-Post hoc exploratory analyses of the COVID STEROID 2 trial

    Acta Anaesthesiologica Scandinavica Date published:

  • Potential effects of lowering the threshold of statistical significance in the field of chronic rhinosinusitis - A meta-research on published randomized controlled trials over last decade

    Brazilian Journal of Otorhinolaryngology Date published: